ArticleGynecologic oncology reports2026
An unforgiving sequela: recurrent radiation-associated sarcoma of the vulva.
Article in Gynecologic oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Radiation-associated sarcomas are rare but aggressive malignancies that can arise as a late complication of radiotherapy. Vulvar sarcomas are particularly uncommon and pose significant diagnostic and therapeutic challenges due to high rates of recurrence and the anatomic complexity of surgical management. Case: We report the case of a 64-year-old woman who developed a high-grade radiation-associated spindle cell sarcoma of the vulva three years after definitive treatment for stage IIIA squamous cell carcinoma of the vulva. Despite multiple surgical resections with initially negative margins, the disease demonstrated rapid and repeated local recurrence, requiring repeated resections including an anterior pelvic exenteration. Although pathology at the time of exenteration confirmed negative margins with no evidence of disease, the patient developed biopsy-proven metastatic sarcoma within five months and was initiated on systemic therapy. She experienced adverse events from systemic treatment, and ultimately opted for home hospice. Conclusion: This case highlights the aggressive clinical behavior of radiation-associated vulvar sarcomas and the limitations of local surgical control despite radical intervention. Early recognition, close surveillance, and a multidisciplinary treatment approach are essential, and further research is needed to define optimal management strategies for this rare entity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.